The first lot of 1.5 L doses of #SputnikV lands in #Hyderabad, with more batches in the weeks ahead. We look forward to rolling out, post quality checks & supply chain pilots. This reaffirms our commitment towards combatting #COVID19 because good health can't wait. #TogetherWeCan
Thank you to everyone who joined us on the webcast with Sadhguru as he spoke to the medical community. Here’s his message to doctors, nurses and health staff who are consciously putting other's well-being above their own, every day. Full video: piped.video/SuFk-iHGRvk#COVID19
Here comes the show-stealing act - a dance by no less than members of our Management Council, setting the stage on fire!!! Through a fun mix of songs, we travelled from Russia to Spain, from Brazil to Africa and finally to where it all started - India. Steering the company by day and wearing their dancing shoes by night, our leaders truly like to work hard and play hard too! 😎
#CelebrationOfExcellence2024#WeAreDrReddys#GoodHealthCantWait#40YearsOfDrReddys
Dr. Reddy's brings to you the live webcast 'With Sadhguru in challenging times'. Hosted by GV Prasad, our Co-Chairman & MD and featuring eminent panel members from healthcare fraternity, the webcast is specially designed for healthworkers. Click to attend: bit.ly/sadhguru-live
We are pleased to announce a special event where our Co-Chairman & MD, GV Prasad will be in conversation with Sadhguru. The webcast, designed for healthcare professionals, will focus on being emotionally resilient despite the challenging times. Register: bit.ly/sadhguru-for-hcps
Soft launched #SputnikV in Hyderabad today to start testing of cold chain logistics with 2-dose regime. Next consignments expected in coming weeks. It will be available for customers in India by mid-June after stock ramp up.
#GoodHealthCantWait#IndiaFightsCOVID19#DRreddys
First doses of #SputnikV administered in India. On the picture Deepak Sapra, Global Head of Custom Pharma Services at @drreddys Laboratories is getting a shot of Sputnik V in Hyderabad. ✌️
Pleased to share that the consignment that arrived today in Hyderabad contains 60,000 doses of the second dose component of the #SputnikV vaccine. Samples from the consignment will be sent for release to the Central Drugs Laboratory.
#DrReddys
#DrReddysNews: Russian Direct Investment Fund (RDIF) and Dr. Reddy’s to cooperate on clinical trials and supply of 100 million doses of Sputnik V vaccine to India. Read more here: bit.ly/SputnikVIndia
.@drreddys is pleased to share that #SputnikV showed strong efficacy, immunogenicity, & safety results in the Interim Phase-3 data on 19866 people in the trials conducted by its partner, RDIF. The efficacy against #COVID19 was reported at 91.6%. Read more bit.ly/SputnikVphase3Results
As a company committed to supporting health workers bravely delivering care in these tough times, we’ve announced a donation of N95 masks worth Rs. 5 crores to the Government of Telangana. Another contribution of Rs. 5 crores is being made to the Andhra Pradesh CM Relief Fund.
Join us in congratulating our Co-Chairman and MD, G V Prasad on being named as one of the top 20 leaders on the @medicine_maker’s 2020 Power List. It recognizes individuals for their inspirational work in driving the pharmaceutical industry forward: bit.ly/2VyxmtM
Dr Reddy’s website readytofightcovid.in/ for Remdesivir stock movement through distribution channel. Currently we are out of stock for Remdesivir. We will regularly update the website as we get new batches of stocks.
Cigarettes have a toxic substance called tar which is used in cementing roads. The more it builds up, the higher is your risk of cancer. This #WorldNoTobaccoDay, make a pledge and #CommitToQuit smoking #tobacco.
#DrReddys
A man of vision and drive, our founder, Dr. Anji Reddy's contribution to the Indian #pharmaceutical industry will be a legacy that lasts forever. Today, we remember him, his life and the work of his hands. #RememberingDrReddy
As the spread the #COVID19 impacts the world around us, Dr. Reddy’s is finding ways to support the members of our communities working on the frontlines. We have donated food, sanitizers, gloves & masks at 12 police stations in Hyderabad & Vizag & to volunteers at Pydibheemavaram.
A step closer to fighting #COVID19, together. We believe that ‘Good #health can’t wait’ and with the emergency use authorization for #SputnikV, we pledge to go the extra mile in ensuring countrywide access to the #vaccine. bit.ly/3tibh15#DrReddys
Our site for #2DG(TM) is now live. Please visit the page for a comprehensive list of cities, towns and #hospitals where 2DG(TM) is available. bit.ly/2V2vFH6#DrReddys
"Of first-generation Indian pharma leaders, Kallam Anji Reddy was perhaps the most passionate about discovering a new molecule...Reddy is credited with building a billion-dollar company - Dr. Reddy’s Laboratories - within a span of 25 years."
Our Chairman @satishkreddy and CEO – API & Services @deepaksapra met Mr. Bill Gates and senior leaders of the @BMGFIndia at the India Pharma Manufacturers’ Roundtable yesterday.
Today, as we pay our respects to our founder, Dr. K. Anji Reddy, we continue to be inspired by his passion for innovation and his firm conviction that for medicines to be useful, they must be affordable and accessible. #RememberingDrReddy
Making medicines affordable. Our Co-Chairman and MD, G V Prasad reflects on how this belief drives him to come to work every day and how Dr. Reddy’s has delivered on this idea through the years. Watch the full conversation with Anil Sachdev here: piped.video/FETMQDbDnW0
We turn a young 39 today!
Founded by the scientist, entrepreneur and philanthropist, Dr. Anji Reddy, our company was incorporated on 24th February, 1984. In less than four decades, we have grown to become a diversified and trusted global pharma player.
#DrReddysArchives | 20 years back today, Dr. Reddy’s became the first pharmaceutical firm in the Asia-Pacific region, outside Japan, to get listed on the New York Stock Exchange. Dr. Reddy’s got listed with the symbol ‘RDY’.
.@drreddys announced the #financial results for the 4th quarter and full year, ending March 31, 2021. The information mentioned is based on the consolidated financial statements under International Financial Reporting Standards. Click here to know more
bit.ly/3eLOK8b
Last Saturday was a day of excitement and nostalgia as we hosted the Mumbai chapter of our alumni meet. It was a great opportunity for us to acknowledge and appreciate everyone who has helped shape Dr. Reddy’s through the years. A big thank you to those who made time to attend!
As the problem of hand sanitizer shortage in the country became known, our teams decided to leverage available resources. We quickly repurposed our production lines and within a few weeks launched ‘ViroWash’. Here’s the link for ordering online: bit.ly/ViroWash
Dr. Reddy's launched #Albendazole tablets USP, a therapeutic equivalent of the standard version of Albenza tablets, 200 mg, approved by the US Food and Drug Administration bit.ly/2MOintM#DrReddys
Today, we fondly remember our founder, Dr. K Anji Reddy, who helped others by empowering them. Inspired by him, we have continued to drive the #SpiritOfGiving at Dr. Reddy’s for over 20 years.
A big milestone for us! Dr. Reddy's has been named the 3rd best employer in healthcare in Kazakhstan. We’d like to take this opportunity to acknowledge the efforts of all our colleagues in Kazakhstan who are working to bring to life our belief of 'Good Health Can't Wait'.
Taking yet another step towards becoming a digital-native organization, we’ve launched ‘Ops Next’, an effort to build best-in-class operations through Digital and Advanced Analytics - furthering our promise to our patients with a more secure supply & improved safety.
#DoingMore
#DrReddysArchives | May 24, 1986 stands as a momentous day in our journey as a company. That is the day Dr. Reddy’s went public with an Initial Public Offering (IPO). Issue opened for Non Resident Indians on May 24, 1986 and for Indian Public on June 5, 1986.
We are honored to be recognized with the API Supplier of the Year Award for the third consecutive year and the CSR Initiative of the Year Award at the Global Generics & Biosimilars Awards in Milan. Congrats to all nominees and winners for their impactful achievements
#GGBAwards
'As easy as breathing' is not a phrase that everyone can use. This #WorldAsthmaDay, we urge you to stay aware about the adverse effects that #asthma can have on one's breathing.
#DrReddys
#DrReddysArchives | A day to acknowledge one of the first steps we took as a company – on May 28, 1985, the construction of our first API manufacturing unit was finished and the facility was inaugurated. The facility is now known as CTO Unit I.
"Pharma industry needs research-push from the government to scale innovation."
As we head towards 2023, our Chairman, @satishkreddy, outlines the challenges & opportunities for drugmakers in innovation spaces in pharma. Read the article for more or visit: bit.ly/3FIiNtv
#DrReddysArchives | Today, we introduce you to ‘Dr. Reddy’s Archives’, a series that captures the key moments from our incredible journey as a company. 18 years ago on this day, we welcomed APJ Abdul Kalam for the inauguration of the new Technology Development Centre.
#DrReddysNews: Dr. Reddy’s partners with FUJIFILM and Global Response Aid for Avigan® (favipiravir), a potential treatment of COVID-19. Read more here: bit.ly/2CRQQCM
Our Chairman, @satishkreddy, on how the pandemic has made the pharma sector more collaborative, and factors that will enable Indian pharma to maintain keen focus on innovation in R&D. #WeAreDrReddys#GoodHealthCantWait#Budget2022
Our Co-Chairman and MD, GV Prasad has been featured in the top 20 leaders on The Medicine Maker’s Power List in the ‘Small Molecules’ category that acknowledges individuals for their work in advancing the pharmaceutical sector and saving lives by developing new medicines.
We wish to bring to your attention that this is incorrect info. Please refer to our tweet below for clarification. Queries related to 2DG can be addressed to 2DG@drreddys.com
Request you to please delete this tweet and re-share correct info. Thank you.
Pleased to announce that Dr. Reddy's and our stepdown subsidiary Aurigene Pharmaceutical Services Limited have signed an MoU with @DNDi and DNDi India Foundation to explore joint opportunities to develop affordable and life-saving new drugs for Neglected Tropical Diseases.
#Pharma majors including Dr. Reddy's collaborate for the clinical trial of investigational oral anti-viral drug Molnupiravir, for the treatment of mild COVID-19 in an outpatient setting in #India. Learn more: bit.ly/3Aeyu8u#COVID19#DrReddys
#DrReddysArchives | It’s been 27 years since we hired the first-ever cargo aircraft to send medicines from Hyderabad to Russia. A truly remarkable moment in the history of Dr. Reddy’s!
Our Co-Chairman & CEO G V Prasad was part of the panel at the India Today South Conclave 2018 discussing the ease of doing business in Telangana, along with the challenges industries in the state faced. Here’s what he had to say. bit.ly/2DPLDrO
The pandemic has made us rethink our relationship and connection with nature. The PM of Bhutan, Dr. Lotay Tshering spoke to our Co-Chairman and MD, G V Prasad, about climate change and how it is not just an environmental but also a social & economic issue: bit.ly/35U9DrF
Ever wonder how a surgeon who also happens to be the PM of a country would define happiness? Watch Bhutan PM, Dr. Lotay Tshering, in conversation with our MD & Co-Chairman, G V Prasad, and find out his views on the notion of Gross National Happiness: bit.ly/35U9DrF
#DrReddysArchives | 20 years ago, @drreddys & Cheminor Drugs Ltd. became a fully integrated company. Thanks to this merger, we’re now India’s 3rd largest #pharmaceutical company. This merger has enabled us to reach out to more people & give them access to expensive #medicines.
Lieutenant General Satish Dua (Retired), one of the most decorated army officers will be speaking at Abhaya Talks. He will pay tribute to all frontline warriors and share his experiences of overcoming fear against all odds. Tune in to bit.ly/3uQMIJy on May 16, 6 PM IST.
Dr. Reddy's spoke to @SputnikInt about the RDIF (Russian Direct Investment Fund) and Dr. Reddy’s collaboration on clinical trials and distribution of the Sputnik V vaccine to India. Read the full interview here: sputniknews.com/interviews/2…
"What really drives me is the science. Can I finally bring a drug into the market that can change the way people live."
It all started with this vision of our founder, Dr. Anji Reddy, just under 40 years ago on February 24, 1984. As we count down to #40YearsOfDrReddys, we'll try to delve into the milestones, the stories, the people, the pillars, the essence of the company. Join us in sharing your stories too in this #2424Journal!
#WeAreDrReddys#GoodHealthCantWait
We’re proud to announce that our CEO G V Prasad has been listed in the @medicine_maker 2018 Power List. This list includes inspirational professionals who contribute to the life-changing work carried out by the biopharmaceutical industry. Read more: bit.ly/2qF1djN
Learn the simple methods of measuring your blood pressure the next time you visit your doctor. An accurate blood pressure measurement is the start of a healthier you, as you become more aware of what your body needs. Act and elevate your quality of life. #WorldHypertensionDay2021
Dr. Reddy’s Laboratories enters into exclusive partnership with HK inno.N Corporation to commercialise novel molecule Tegoprazan in India & select Emerging Markets. For more details: bit.ly/3l04tmi
Applying a QbD development approach can benefit #API quality. Gain insights into the #Fosaprepitant API example that outlines how a control plan of critical quality attributes at an API stage can impact the formulation quality. myapi.drreddys.com/Fosaprepi…
We are honoured to be recognized at the CPhI Pharma Awards 2020 as the winner in the category of ‘Excellence in Pharma: Sustainability’, for our Watershed Program. Congratulations to all the finalists in #Sustainability category, as well as winners of all the other categories!
For information about the availability of the Sputnik V vaccine, please visit bit.ly/Sputnik-vaccine. Our site has a comprehensive list of cities, towns and hospitals where dose 1 of the vaccine is available.
How much do you know about #Parkinson's disease? This Parkinson's Awareness Month, we hope to engage and educate people about the adverse effects of this disease to help improve the quality of life for patients affected by it.
From the moment we appeared on an ultrasound, our lives changed because we had them. On this day, we celebrate the loving #parents who cared for our #health and wellbeing even before day one. Celebrating #GlobalDayOfParents#ParentHood#DrReddys
With sections of our society being hit by economic impact of #COVID19, we’re taking steps to protect the income of our extended workforce. Contract workers who would’ve normally come to work are being paid in full & contract staff onsite are being paid an added hardship allowance
#DrReddysNews: Dr. Reddy’s announces its consolidated financial results for the fourth quarter (Q4 FY20) and full year (FY20) ended March 31, 2020. Read more here: bit.ly/DrReddysQ4FY20
#DrReddysArchives | The first step that led us to enter the highly regulated market in the US was taken on August 13, 1994. On this date, Dr. Anji Reddy laid the foundation stone for our first generics facility that would manufacture drugs for the US market.
We wish to bring to your attention that this is incorrect info. Please refer to our tweet below for clarification. Queries related to 2DG can be addressed to 2DG@drreddys.com
Request you to please delete this tweet and re-share correct info. Thank you.
As we celebrate 74 years of India’s Independence, let us recognise the efforts of doctors, healthcare workers & scientists who are helping us move towards the most important freedom in these times, the freedom of #GoodHealth. From all of us at Dr. Reddy’s, #HappyIndependenceDay!
Join us today for a webinar with Col. Lalit Rai, who was awarded the Vir Chakra for his bravery during the Kargil War. Designed especially for health professionals, the webinar is about finding courage to navigate the challenges thrown up by this crisis: bit.ly/courage-in-crisis
Spreading awareness about #malaria is vital. This harmful disease is transmitted through the bite of an infected Anopheles #mosquito and has recorded millions of cases worldwide. You can stay safe by using repellents, wearing long sleeves and using mosquito meshes.
#DrReddys
Over the last year, with an approach of “do no harm” and applying principles of “green chemistry” we witnessed success in reducing our impact on environment and climate change through our processes bit.ly/DrReddysSustainabilit…
Responding to the urgent needs of vulnerable communities is a key aspect of our response to the #COVID19 crisis. In Baddi, Himachal Pradesh, we are continuing to support the hardest hit families through distribution of dry food rations. #HelpingHands
With over 500 vital functions, the liver is one of the most important organs in our body. This #WorldLiverDay, we urge you to preserve your liver by eating right and exercising regularly.
#DrReddys
Pleased to announce the first Dr. Kallam Anji Reddy Memorial lecture on March 15, 2023. With 'Science, Society and Sustainability' at its core, the lecture series will represent these key pillars of Dr. Anji Reddy's life and legacy.
Dr. Reddy’s is proud to be included in #DowJonesSustainabilityIndices for the fourth consecutive year! We are one of 12 Indian companies that made it to Emerging Market Index in 2019. It’s heartening to see our efforts recognized. @RobecoSAM #DJSI#Sustainability
As we navigate the challenge of #COVID19, our heartfelt thanks goes out to each of our employees at Dr. Reddy’s, who continue to make safe, life-saving medicines for patients every day. It’s through your determined efforts that we stay true to our belief of #GoodHealthCantWait.
G V Prasad gets candid about his life with CEO India, and highlights his philosophy of 'doing things the right way'. Read more here: bit.ly/CEOIndiaPrasad
The #Phase3 trial for Sputnik V vaccine will be conducted on #1500Subjects as a part of the randomized, double-blind, parallel-group, placebo-controlled study. bit.ly/2XQmdF3#DrReddys
In our ongoing series of webinars, we’re inviting leaders to share advice for navigating these uncertain times. Our next speaker, Dr. Lotay Tshering, is the remarkable surgeon PM of Bhutan. Catch him in conversation with our Co-Chairman & MD, G V Prasad: bit.ly/BhutanPM
Pleased to share that we have won the prestigious Gold Shield in our category from the Institute of Chartered Accountants of India (ICAI) for Excellence in Financial Reporting for 2021-22!
In our upcoming webinar, Dr. Lotay Tshering, @PMBhutan will speak on the concept of ‘Gross National Happiness’ that guides the government of Bhutan. Dr. Tshering will be in conversation with our Co-Chairman and MD, G V Prasad. Tune in from 5:30pm (IST): bit.ly/35U9DrF
Today, as India observes #DoctorsDay, our deepest gratitude goes out to all the doctors for putting patients first at all times, but especially now, as you lead the struggle against #COVID19. Thank you for the gift of health you give to all of us. #NationalDoctorsDay2020.
Dr. Reddy's receives emergency-use authorisation to launch its oral anti-viral drug Molflu(TM) (Molnupiravir 200mg capsules) in India for the treatment of COVID-19. For details: bit.ly/3Js5GOq